Concepedia

Author

Vincent P. Rocco

Eli Lilly (United States)

Also Known As

V P Rocco, V ROCCO, V. P. ROCCO, V. Rocco, Vincent P Rocco, Vincent P. Rocco, Vincent Rocco

27

Publications

492

Citations

13

H-Index

20

Concepts

All Affiliations

Eli Lilly (United States)Yale University
VP

About

Vincent P. Rocco is an author at Eli Lilly (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

184

2

Biochemistry

2

2

31

3

Engineering

1

1

17

4

Health Sciences

1

1

28

5

Chemistry

1

1

28

Vincent P. Rocco

×

13

Publications

465

Citations

13

H-Index

YearCitations

Pharmacologic Characterization of the Cloned Human Trace Amine-Associated Receptor1 (TAAR1) and Evidence for Species Differences with the Rat TAAR1

David B. Wainscott, Sheila P. Little, Tinggui Yin,

Journal of Pharmacology and Experimental Therapeutics

2006

107

Effects of Topically Administered Neuroprotective Drugs in Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial

Rafael Simó, Cristina Hernández, Massimo Porta,

Diabetes

2018

90

Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1

Kumiko Takeuchi, Todd J. Kohn, Nicholas A Honigschmidt,

Bioorganic & Medicinal Chemistry Letters

2003

48

Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 4

Vincent P. Rocco, Patrick Spinazze, Todd J. Kohn,

Bioorganic & Medicinal Chemistry Letters

2004

33

Enantiomerically homogeneous intermediates toward the synthesis of descarbamoylcalicheamicinone

Dennis S. Yamashita, Vincent P. Rocco, Samuel J. Danishefsky

Tetrahedron Letters

1991

29

Intramolecular [2 + 2] photocycloaddition of 4-substituted cyclopent-2-en-1-ones

William G. Dauben, Vincent P. Rocco, Gideon Shapiro

The Journal of Organic Chemistry

1985

28

Substrate specificity in enzymatically mediated trans acetylation reactions of calicheamicinone intermediates

Vincent P. Rocco, Samuel J. Danishefsky, Gayle K. Schulte

Tetrahedron Letters

1991

23

Advances Toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 2

Kumiko Takeuchi, Todd J. Kohn, Nicholas A Honigschmidt,

Bioorganic & Medicinal Chemistry Letters

2003

21

Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 3

Kumiko Takeuchi, Todd J. Kohn, Nicholas A Honigschmidt,

Bioorganic & Medicinal Chemistry Letters

2003

20

Advances toward new antidepressants beyond SSRIs: 1-Aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 5

Kumiko Takeuchi, Todd J. Kohn, Nicholas A Honigschmidt,

Bioorganic & Medicinal Chemistry Letters

2005

20

Page 1